Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M MacPhee

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Clinical Chemistry|October 26, 2005
CYP3A5 genotype does not influence the blood concentration of tacrolimus measured with the Abbott immunoassayMichelle Moreton, Salim Fredericks, Denise A McKeown, et al.
The Journal of Antimicrobial Chemotherapy|December 6, 2001
Tetracycline delivery from fibrin controls peritoneal infection without measurable systemic antibioticC J Woolverton, J A Fulton, S J Salstrom, et al.
Journal of Translational Medicine|April 18, 2015
Validation of a continuous infusion of low dose Iohexol to measure glomerular filtration rate: randomised clinical trialJohn J Dixon, Katie Lane, R Neil Dalton, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 19, 2004
The influence of pharmacogenetics on the time to achieve target tacrolimus concentrations after kidney transplantationIain A M MacPhee, Salim Fredericks, Tracy Tai, et al.
Critical Care Medicine|December 2, 2017
Continuous Infusion of Low-Dose Iohexol Measures Changing Glomerular Filtration Rate in Critically Ill PatientsJohn J Dixon, Katie Lane, R Neil Dalton, et al.
Transplantation|December 20, 2002
Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome p4503A5 and P-glycoprotein correlate with dose requirementIain A M Macphee, Salim Fredericks, Tracy Tai, et al.
Transplantation|February 25, 2005
Tacrolimus pharmacogenetics: the CYP3A5*1 allele predicts low dose-normalized tacrolimus blood concentrations in whites and South AsiansIain A M Macphee, Salim Fredericks, Maha Mohamed, et al.
Annals of Clinical Biochemistry|September 20, 2005
Genotyping cytochrome P450 3A5 using the Light CyclerSalim Fredericks, Michelle Moreton, Iain A M MacPhee, et al.
The Journal of Urology|February 15, 2001
Treatment of grade 4 renal stab wounds with absorbable fibrin adhesive bandage in a porcine modelA F Morey, J G Anema, R Harris, et al.
Clinical Transplantation|April 12, 2007
Multi-drug resistance gene-1 (MDR-1) haplotypes and the CYP3A5*1 genotype have no influence on ciclosporin dose requirements as assessed by C0 or C2 measurementsSalim Fredericks, AnaMaria Jorga, Iain A M MacPhee, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Clinical Chemistry|October 26, 2005
CYP3A5 genotype does not influence the blood concentration of tacrolimus measured with the Abbott immunoassayMichelle Moreton, Salim Fredericks, Denise A McKeown, et al.
The Journal of Antimicrobial Chemotherapy|December 6, 2001
Tetracycline delivery from fibrin controls peritoneal infection without measurable systemic antibioticC J Woolverton, J A Fulton, S J Salstrom, et al.
Journal of Translational Medicine|April 18, 2015
Validation of a continuous infusion of low dose Iohexol to measure glomerular filtration rate: randomised clinical trialJohn J Dixon, Katie Lane, R Neil Dalton, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 19, 2004
The influence of pharmacogenetics on the time to achieve target tacrolimus concentrations after kidney transplantationIain A M MacPhee, Salim Fredericks, Tracy Tai, et al.
Critical Care Medicine|December 2, 2017
Continuous Infusion of Low-Dose Iohexol Measures Changing Glomerular Filtration Rate in Critically Ill PatientsJohn J Dixon, Katie Lane, R Neil Dalton, et al.
Transplantation|December 20, 2002
Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome p4503A5 and P-glycoprotein correlate with dose requirementIain A M Macphee, Salim Fredericks, Tracy Tai, et al.
Transplantation|February 25, 2005
Tacrolimus pharmacogenetics: the CYP3A5*1 allele predicts low dose-normalized tacrolimus blood concentrations in whites and South AsiansIain A M Macphee, Salim Fredericks, Maha Mohamed, et al.
Annals of Clinical Biochemistry|September 20, 2005
Genotyping cytochrome P450 3A5 using the Light CyclerSalim Fredericks, Michelle Moreton, Iain A M MacPhee, et al.
The Journal of Urology|February 15, 2001
Treatment of grade 4 renal stab wounds with absorbable fibrin adhesive bandage in a porcine modelA F Morey, J G Anema, R Harris, et al.
Clinical Transplantation|April 12, 2007
Multi-drug resistance gene-1 (MDR-1) haplotypes and the CYP3A5*1 genotype have no influence on ciclosporin dose requirements as assessed by C0 or C2 measurementsSalim Fredericks, AnaMaria Jorga, Iain A M MacPhee, et al.
Pageof 8